Acetic Acid

Acetic Acid

SCHEMBL1176753

CC(=O)O.CCOc1cccc2c1Cc1ccccc1O2

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
GLA P06280 1/20 0.43
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
APAF1 O14727 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.40
HSP90B1 P14625 1/20 0.39
TRAP1 Q12931 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 4/20 0.39
TP53 P04637 1/20 0.39
ACSL1 P33121 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
HPGD P15428 1/20 0.39
NPC1 O15118 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171010 0.92 MAOA (0.48) L3MBTL1GLAMAOAMAOBKMT2A
Benzoic Acid SCHEMBL1723033 0.91 MRGPRX4 (0.47) L3MBTL1GLAMAOAMAOBKMT2A
Methyl Benzoate SCHEMBL8468464 0.88 TSHR (0.43) L3MBTL1GLAKMT2AMEN1GAA
SCHEMBL8006592 0.87 KMT2A (0.38) L3MBTL1GLAMAOAMAOBKMT2A
SCHEMBL8006594 0.85 MAOA (0.37) L3MBTL1GLAMAOAMAOBKMT2A
Acetic Acid SCHEMBL1060685 0.84 MAOA (0.43) MAOAMAOBLMNAACSL1ALDH1A1
SCHEMBL4745471 0.83 CXCR5 (0.42) L3MBTL1GLAMAOAMAOBKMT2A
Ether SCHEMBL1176750 0.82 MAOA (0.39) MAOAMAOBACSL1ALDH1A1HPGD
SCHEMBL411459 0.81 MAOA (0.46) L3MBTL1MAOAMAOBLMNAMAPT
SCHEMBL28207675 0.80 MAOA (0.42) MAOAMAOBKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2861206-B1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR OREAL (FR) 2019-06-12 EP claimed
EP-3386476-A1 COMPOSITION COMPRISING A POLYMER CONTAINING A SULFONIC MONOMER AND A PYRIDINEDICARBOXYLIC ACID DERIVATIVE, AND COSMETIC TREATMENT METHOD L'Oréal (FR) 2018-10-17 EP claimed
WO-2017097849-A1 COMPOSITION COMPRISING A POLYMER CONTAINING A SULFONIC MONOMER AND A PYRIDINEDICARBOXYLIC ACID DERIVATIVE, AND COSMETIC TREATMENT METHOD L'OREAL (FR) 2017-06-15 WO claimed
EP-2861206-A1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR L'OREAL (FR) 2015-04-22 EP claimed
WO-2013186486-A1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR L'OREAL (FR) 2013-12-19 WO claimed
US-20120308671-A1 NASAL OINTMENT BASED ON WHITE PETROLEUM JELLY PHYT-IMMUN GMBH (DE) 2012-12-06 US claimed
EP-1286657-B1 NASAL OINTMENT BASED ON WHITE PETROLEUM JELLY PHYT IMMUN GMBH (DE) 2010-12-29 EP claimed
US-20030161899-A1 Nasal ointment based on white petroleum jelly PHYT IMMUN-GMBH (DE) 2003-08-28 US claimed
US-20020155962-A1 Nonaqueous hair styling composition and method of use ANDREW JERGENS COMPANY, THE 2002-10-24 US claimed
US-20020082305-A1 Petrolatum-based nose ointment THEISS PETER (DE) 2002-06-27 US claimed
US-20260090977-A1 WATER-IN-OIL COSMETIC COMPOSITION SHINETSU CHEMICAL CO (JP) 2026-04-02 US disclosed
EP-4620455-A1 COSMETIC HAVING CROSSLINKED ORGANOSILOXANE POLYMER SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-24 EP disclosed
CN-107541528-B Saccharomyces veronae fermentation broth of germinated brown rice 株式会社芳珂 2022-09-23 CN disclosed
CN-113318001-A Skin cleanser and lamellar formation promoter containing Trehangelin 株式会社芳珂 2021-08-31 CN disclosed
EP-2861206-B1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR OREAL (FR) 2019-06-12 EP disclosed
US-5932228-A ADMINISTERING BENZOYL PEROXIDE AND COMPOUND THAT REDUCES SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1999-08-03 US disclosed
EP-0787005-A2 DERMATOLOGICAL COMPOSITIONS CONTAINING BENZOYL PEROXIDE AND A COMPOUND REDUCING SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1997-08-06 EP disclosed
US-5545407-A ANTIACNE AGENTS THE PROCTER & GAMBLE COMPANY (US) 1996-08-13 US disclosed
WO-1996012498-A2 DERMATOLOGICAL COMPOSITIONS CONTAINING BENZOYL PEROXIDE AND A COMPOUND REDUCING SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1996-05-02 WO disclosed
US-5445823-A Benzoyl peroxide and a compound for reducing skin irritation associated with it THE PROCTER & GAMBLE COMPANY (US) 1995-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090977-A1 WATER-IN-OIL COSMETIC COMPOSITION DEGS1, SQLE, FDFT1 L3MBTL1 1401/4885GLA 675/4885MAOA 4199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.